| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/28/2001 | WO2001045703A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 06/28/2001 | WO2001045702A1 SUBSTITUTED ACYLHYDROXAMIC ACIDS AND METHOD OF REDUCING TNFα LEVELS |
| 06/28/2001 | WO2001045690A2 Use of bvdu for inhibiting the growth of hyperproliferative cells |
| 06/28/2001 | WO2001045689A2 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 06/28/2001 | WO2001045661A2 Cosmetic and/or pharmaceutical preparations |
| 06/28/2001 | WO2001045509A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs |
| 06/28/2001 | WO2001040442A8 Novel bacterial isolate and the preparation and use of its active metabolites |
| 06/28/2001 | WO2001014402A8 Antisense modulation of focal adhesion kinase expression |
| 06/28/2001 | WO2001005414A8 Algae protein polysaccharide extraction and use thereof |
| 06/28/2001 | WO2001002407A3 Taxane derivatives and processes for the preparation thereof |
| 06/28/2001 | WO2000078927A3 Spheroid preparation |
| 06/28/2001 | WO2000077186A3 Bacterial protection against stress |
| 06/28/2001 | WO2000076527A3 New molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy |
| 06/28/2001 | WO2000076450A3 Recombinant adenoviruses for the sodium/iodide symporter (nis) |
| 06/28/2001 | WO2000075144A3 Peroxynitrite decomposition catalysts and methods of use thereof |
| 06/28/2001 | WO2000074693A3 Immunity generation |
| 06/28/2001 | WO2000073344A3 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 06/28/2001 | WO2000070351A3 Protein-protein interactions and methods for identifying them |
| 06/28/2001 | WO2000070049A3 Extracellular signaling molecules |
| 06/28/2001 | WO2000070047A3 Full-length molecules expressed in human tissues |
| 06/28/2001 | WO2000068247A3 Serine proteases |
| 06/28/2001 | WO2000067697A3 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells |
| 06/28/2001 | WO2000063236A3 Adhesion modulatory peptides and methods for use |
| 06/28/2001 | WO2000061753A3 Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/28/2001 | WO2000061180A3 Products and methods for treating ptp lar related diseases |
| 06/28/2001 | WO2000060079A3 New members of tnf and tnfr families |
| 06/28/2001 | WO2000057865A3 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
| 06/28/2001 | WO2000055321A3 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 06/28/2001 | WO2000044774A3 Inhibition of stat3 signal transduction for human cancer therapy |
| 06/28/2001 | WO1999064461A9 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 06/28/2001 | DE19963052A1 Topical composition for preventing radiation-induced skin cancer, e.g. due to sunbathing or radiotherapy, containing azole compound such as bifonazole or clotrimazole |
| 06/28/2001 | DE19962583A1 New antibodies specific for plasma cells, useful for treatment and diagnosis of autoimmune diseases and plasma cell tumors |
| 06/28/2001 | DE19962300A1 New N-benzylindolyl glyoxylic acid derivatives are useful as antitumor agents |
| 06/28/2001 | DE19960640A1 Neue Stromelysin Inhibitoren New stromelysin inhibitors |
| 06/28/2001 | DE19959045A1 Adeno-associated virus vectors that express monocyte chemotactic protein-1, useful for gene therapy of cancers, promotion of angiogenesis and treatment of inflammation |
| 06/28/2001 | DE19957065A1 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 06/28/2001 | CA2399584A1 Non peptide tachykinin receptor antagonists |
| 06/28/2001 | CA2395520A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 06/28/2001 | CA2395513A1 Methods and compounds for inhibiting mrp1 |
| 06/28/2001 | CA2395466A1 Interventions to mimic the effects of calorie restriction |
| 06/28/2001 | CA2395435A1 Cosmid dna constructs and methods of making and using the same |
| 06/28/2001 | CA2395369A1 Cytokine zcyto18 |
| 06/28/2001 | CA2395300A1 Novel compounds |
| 06/28/2001 | CA2395212A1 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | CA2395208A1 Nucleic acid vaccination |
| 06/28/2001 | CA2395202A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | CA2395191A1 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 06/28/2001 | CA2395136A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 06/28/2001 | CA2395113A1 Pyrazole cyclic amp-specific pde inhibitors |
| 06/28/2001 | CA2395102A1 Human kinases |
| 06/28/2001 | CA2395007A1 Transporters and ion channels |
| 06/28/2001 | CA2394864A1 Novel compounds |
| 06/28/2001 | CA2394852A1 Substituted pyrroles |
| 06/28/2001 | CA2394834A1 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | CA2394789A1 Proteases |
| 06/28/2001 | CA2394741A1 Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions |
| 06/28/2001 | CA2394604A1 Substituted acylhydroxamic acids and method of reducing tnf.alpha. levels |
| 06/28/2001 | CA2394049A1 Vesicle trafficking proteins |
| 06/28/2001 | CA2394015A1 Tweak receptor |
| 06/28/2001 | CA2393855A1 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | CA2393767A1 Molecules derived from mechanism based drug design |
| 06/28/2001 | CA2393724A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 06/28/2001 | CA2393367A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | CA2393363A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | CA2393359A1 Aromatic phosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors |
| 06/28/2001 | CA2392873A1 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii |
| 06/28/2001 | CA2392787A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2392150A1 Diamidine compounds as dna minor groove binders |
| 06/28/2001 | CA2391594A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2389479A1 Butyne diol derivatives |
| 06/28/2001 | CA2388669A1 Inhibitors of farnesyl protein transferase |
| 06/28/2001 | CA2387579A1 Farnesyl transferase inhibitors |
| 06/28/2001 | CA2384326A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs |
| 06/27/2001 | EP1111054A1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them |
| 06/27/2001 | EP1111050A2 Human procalcitonin, its production and use |
| 06/27/2001 | EP1111048A2 Neutral amino acid transporter and gene thereof |
| 06/27/2001 | EP1111039A1 Immature autologous clinical grade dendritic cells intended for vaccination of cancer patients |
| 06/27/2001 | EP1110970A1 Anti-Procalcitonin antibody, their production and use |
| 06/27/2001 | EP1110957A1 Benzazole derivatives and their use as JNK modulators |
| 06/27/2001 | EP1110953A1 Quinazoline derivatives |
| 06/27/2001 | EP1110552A1 Use of a compound with affinity for the mitochondrial benzodiazepine receptor in cancer therapy |
| 06/27/2001 | EP1109937A1 A novel method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 06/27/2001 | EP1109926A1 Condensed plasmid-liposome complex for transfection |
| 06/27/2001 | EP1109921A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof |
| 06/27/2001 | EP1109919A2 Rationally designed heparinases derived from heparinase i and ii |
| 06/27/2001 | EP1109918A2 Polypeptides, polynucleotides and uses thereof |
| 06/27/2001 | EP1109907A1 Human cell junction pdz protein |
| 06/27/2001 | EP1109905A1 Genes encoding for the human and murine death inducer-obliterator-1 |
| 06/27/2001 | EP1109904A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof |
| 06/27/2001 | EP1109903A2 Human rna-associated proteins |
| 06/27/2001 | EP1109900A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 06/27/2001 | EP1109896A1 Adenovirus formulations for gene therapy |
| 06/27/2001 | EP1109895A1 Endothelial cell proliferation inhibitors derived from human prothrombin |
| 06/27/2001 | EP1109833A2 Compositions and methods for the treatment of tumors |
| 06/27/2001 | EP1109832A1 Ozf protein-specific monoclonal antibodies and their diagnostic therapeutic uses |
| 06/27/2001 | EP1109831A2 Cyctotoxic peptides modified by bulky or lipophilic moieties |
| 06/27/2001 | EP1109829A1 Human latent transforming growth factor beta binding protein 3 |
| 06/27/2001 | EP1109827A2 Bioactive peptides |
| 06/27/2001 | EP1109824A1 Novel bag proteins and nucleic acid molecules encoding them |
| 06/27/2001 | EP1109818A1 Phosphoepoxides, method for making same and uses |